351 related articles for article (PubMed ID: 23184418)
1. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma.
Dubuc AM; Remke M; Korshunov A; Northcott PA; Zhan SH; Mendez-Lago M; Kool M; Jones DT; Unterberger A; Morrissy AS; Shih D; Peacock J; Ramaswamy V; Rolider A; Wang X; Witt H; Hielscher T; Hawkins C; Vibhakar R; Croul S; Rutka JT; Weiss WA; Jones SJ; Eberhart CG; Marra MA; Pfister SM; Taylor MD
Acta Neuropathol; 2013 Mar; 125(3):373-84. PubMed ID: 23184418
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the genomic complexity underlying medulloblastoma.
Jones DT; Jäger N; Kool M; Zichner T; Hutter B; Sultan M; Cho YJ; Pugh TJ; Hovestadt V; Stütz AM; Rausch T; Warnatz HJ; Ryzhova M; Bender S; Sturm D; Pleier S; Cin H; Pfaff E; Sieber L; Wittmann A; Remke M; Witt H; Hutter S; Tzaridis T; Weischenfeldt J; Raeder B; Avci M; Amstislavskiy V; Zapatka M; Weber UD; Wang Q; Lasitschka B; Bartholomae CC; Schmidt M; von Kalle C; Ast V; Lawerenz C; Eils J; Kabbe R; Benes V; van Sluis P; Koster J; Volckmann R; Shih D; Betts MJ; Russell RB; Coco S; Tonini GP; Schüller U; Hans V; Graf N; Kim YJ; Monoranu C; Roggendorf W; Unterberg A; Herold-Mende C; Milde T; Kulozik AE; von Deimling A; Witt O; Maass E; Rössler J; Ebinger M; Schuhmann MU; Frühwald MC; Hasselblatt M; Jabado N; Rutkowski S; von Bueren AO; Williamson D; Clifford SC; McCabe MG; Collins VP; Wolf S; Wiemann S; Lehrach H; Brors B; Scheurlen W; Felsberg J; Reifenberger G; Northcott PA; Taylor MD; Meyerson M; Pomeroy SL; Yaspo ML; Korbel JO; Korshunov A; Eils R; Pfister SM; Lichter P
Nature; 2012 Aug; 488(7409):100-5. PubMed ID: 22832583
[TBL] [Abstract][Full Text] [Related]
3. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.
Pugh TJ; Weeraratne SD; Archer TC; Pomeranz Krummel DA; Auclair D; Bochicchio J; Carneiro MO; Carter SL; Cibulskis K; Erlich RL; Greulich H; Lawrence MS; Lennon NJ; McKenna A; Meldrim J; Ramos AH; Ross MG; Russ C; Shefler E; Sivachenko A; Sogoloff B; Stojanov P; Tamayo P; Mesirov JP; Amani V; Teider N; Sengupta S; Francois JP; Northcott PA; Taylor MD; Yu F; Crabtree GR; Kautzman AG; Gabriel SB; Getz G; Jäger N; Jones DT; Lichter P; Pfister SM; Roberts TM; Meyerson M; Pomeroy SL; Cho YJ
Nature; 2012 Aug; 488(7409):106-10. PubMed ID: 22820256
[TBL] [Abstract][Full Text] [Related]
4. Novel mutations target distinct subgroups of medulloblastoma.
Robinson G; Parker M; Kranenburg TA; Lu C; Chen X; Ding L; Phoenix TN; Hedlund E; Wei L; Zhu X; Chalhoub N; Baker SJ; Huether R; Kriwacki R; Curley N; Thiruvenkatam R; Wang J; Wu G; Rusch M; Hong X; Becksfort J; Gupta P; Ma J; Easton J; Vadodaria B; Onar-Thomas A; Lin T; Li S; Pounds S; Paugh S; Zhao D; Kawauchi D; Roussel MF; Finkelstein D; Ellison DW; Lau CC; Bouffet E; Hassall T; Gururangan S; Cohn R; Fulton RS; Fulton LL; Dooling DJ; Ochoa K; Gajjar A; Mardis ER; Wilson RK; Downing JR; Zhang J; Gilbertson RJ
Nature; 2012 Aug; 488(7409):43-8. PubMed ID: 22722829
[TBL] [Abstract][Full Text] [Related]
5. The genetic landscape of the childhood cancer medulloblastoma.
Parsons DW; Li M; Zhang X; Jones S; Leary RJ; Lin JC; Boca SM; Carter H; Samayoa J; Bettegowda C; Gallia GL; Jallo GI; Binder ZA; Nikolsky Y; Hartigan J; Smith DR; Gerhard DS; Fults DW; VandenBerg S; Berger MS; Marie SK; Shinjo SM; Clara C; Phillips PC; Minturn JE; Biegel JA; Judkins AR; Resnick AC; Storm PB; Curran T; He Y; Rasheed BA; Friedman HS; Keir ST; McLendon R; Northcott PA; Taylor MD; Burger PC; Riggins GJ; Karchin R; Parmigiani G; Bigner DD; Yan H; Papadopoulos N; Vogelstein B; Kinzler KW; Velculescu VE
Science; 2011 Jan; 331(6016):435-9. PubMed ID: 21163964
[TBL] [Abstract][Full Text] [Related]
6. MLL2 and KDM6A mutations in patients with Kabuki syndrome.
Miyake N; Koshimizu E; Okamoto N; Mizuno S; Ogata T; Nagai T; Kosho T; Ohashi H; Kato M; Sasaki G; Mabe H; Watanabe Y; Yoshino M; Matsuishi T; Takanashi J; Shotelersuk V; Tekin M; Ochi N; Kubota M; Ito N; Ihara K; Hara T; Tonoki H; Ohta T; Saito K; Matsuo M; Urano M; Enokizono T; Sato A; Tanaka H; Ogawa A; Fujita T; Hiraki Y; Kitanaka S; Matsubara Y; Makita T; Taguri M; Nakashima M; Tsurusaki Y; Saitsu H; Yoshiura K; Matsumoto N; Niikawa N
Am J Med Genet A; 2013 Sep; 161A(9):2234-43. PubMed ID: 23913813
[TBL] [Abstract][Full Text] [Related]
7. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma.
Northcott PA; Nakahara Y; Wu X; Feuk L; Ellison DW; Croul S; Mack S; Kongkham PN; Peacock J; Dubuc A; Ra YS; Zilberberg K; McLeod J; Scherer SW; Sunil Rao J; Eberhart CG; Grajkowska W; Gillespie Y; Lach B; Grundy R; Pollack IF; Hamilton RL; Van Meter T; Carlotti CG; Boop F; Bigner D; Gilbertson RJ; Rutka JT; Taylor MD
Nat Genet; 2009 Apr; 41(4):465-72. PubMed ID: 19270706
[TBL] [Abstract][Full Text] [Related]
8. Synergistic triad epistasis of epigenetic H3K27me modifier genes, EZH2, KDM6A, and KDM6B, in gastric cancer susceptibility.
Lee SW; Park DY; Kim MY; Kang C
Gastric Cancer; 2019 May; 22(3):640-644. PubMed ID: 30374835
[TBL] [Abstract][Full Text] [Related]
9. Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC.
Ibragimova I; Maradeo ME; Dulaimi E; Cairns P
Epigenetics; 2013 May; 8(5):486-93. PubMed ID: 23644518
[TBL] [Abstract][Full Text] [Related]
10. OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels.
Bunt J; Hasselt NA; Zwijnenburg DA; Koster J; Versteeg R; Kool M
Acta Neuropathol; 2013 Mar; 125(3):385-94. PubMed ID: 23179372
[TBL] [Abstract][Full Text] [Related]
11. UTX and MLL4 coordinately regulate transcriptional programs for cell proliferation and invasiveness in breast cancer cells.
Kim JH; Sharma A; Dhar SS; Lee SH; Gu B; Chan CH; Lin HK; Lee MG
Cancer Res; 2014 Mar; 74(6):1705-17. PubMed ID: 24491801
[TBL] [Abstract][Full Text] [Related]
12. Examining the impact of gene variants on histone lysine methylation.
Van Rechem C; Whetstine JR
Biochim Biophys Acta; 2014 Dec; 1839(12):1463-76. PubMed ID: 24859469
[TBL] [Abstract][Full Text] [Related]
13. Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27).
McCabe MT; Graves AP; Ganji G; Diaz E; Halsey WS; Jiang Y; Smitheman KN; Ott HM; Pappalardi MB; Allen KE; Chen SB; Della Pietra A; Dul E; Hughes AM; Gilbert SA; Thrall SH; Tummino PJ; Kruger RG; Brandt M; Schwartz B; Creasy CL
Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2989-94. PubMed ID: 22323599
[TBL] [Abstract][Full Text] [Related]
14. Redefining the molecular substructure of medulloblastoma.
Benmaamar R
Lancet Oncol; 2017 Sep; 18(9):e514. PubMed ID: 28757377
[No Abstract] [Full Text] [Related]
15. Trimethylation of H3K27 during human cerebellar development in relation to medulloblastoma.
Mir SE; Smits M; Biesmans D; Julsing M; Bugiani M; Aronica E; Kaspers GJL; Cloos J; Würdinger T; Hulleman E
Oncotarget; 2017 Oct; 8(45):78978-78988. PubMed ID: 29108280
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of Ezh2 Upregulates Gfi1 and Drives Aggressive Myc-Driven Group 3 Medulloblastoma.
Vo BT; Li C; Morgan MA; Theurillat I; Finkelstein D; Wright S; Hyle J; Smith SMC; Fan Y; Wang YD; Wu G; Orr BA; Northcott PA; Shilatifard A; Sherr CJ; Roussel MF
Cell Rep; 2017 Mar; 18(12):2907-2917. PubMed ID: 28329683
[TBL] [Abstract][Full Text] [Related]
17. Uncoupling histone H3K4 trimethylation from developmental gene expression via an equilibrium of COMPASS, Polycomb and DNA methylation.
Douillet D; Sze CC; Ryan C; Piunti A; Shah AP; Ugarenko M; Marshall SA; Rendleman EJ; Zha D; Helmin KA; Zhao Z; Cao K; Morgan MA; Singer BD; Bartom ET; Smith ER; Shilatifard A
Nat Genet; 2020 Jun; 52(6):615-625. PubMed ID: 32393859
[TBL] [Abstract][Full Text] [Related]
18. Clinico-pathological description of three paediatric medulloblastoma cases with MLL2/3 gene mutations.
López GY; Grant GA; Fuchs HE; Leithe LG; Gururangan S; Bigner DD; Yan H; McLendon RE; He Y
Neuropathol Appl Neurobiol; 2014 Feb; 40(2):217-20. PubMed ID: 23659599
[No Abstract] [Full Text] [Related]
19. KDM6A point mutations cause Kabuki syndrome.
Miyake N; Mizuno S; Okamoto N; Ohashi H; Shiina M; Ogata K; Tsurusaki Y; Nakashima M; Saitsu H; Niikawa N; Matsumoto N
Hum Mutat; 2013 Jan; 34(1):108-10. PubMed ID: 23076834
[TBL] [Abstract][Full Text] [Related]
20. Absence of deletion and duplication of MLL2 and KDM6A genes in a large cohort of patients with Kabuki syndrome.
Priolo M; Micale L; Augello B; Fusco C; Zucchetti F; Prontera P; Paduano V; Biamino E; Selicorni A; Mammì C; Laganà C; Zelante L; Merla G
Mol Genet Metab; 2012 Nov; 107(3):627-9. PubMed ID: 22840376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
